Transmutex SA, a Geneva-Based Company, Raises Over CHF 20 Million in an Extension of Its Series A to Further Develop and Commercialize Its Subcritical Nuclear Energy System

Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, announces a new round of financing to further develop its pivotal solution to a safer, lower-cost, proliferation-resistant nuclear energy technology. The Series A2 round is co-led by Union Square Ventures and Steel Atlas.

Related Keywords

New York ,United States ,Italy ,United Kingdom ,Geneva ,Genè ,Switzerland ,France ,China ,Monte Carlo ,Toscana ,Canton ,Talal Attieh ,Giovanni Anelli ,Albert Wenger ,Cameron Porter ,Helen Lin ,Laura Thomson ,Franklin Servan Schreiber ,Ansaldo Nucleare ,Antonio Gambardella ,Union Square Ventures ,National Center ,Ipcc ,International Collaborations With Leaders In Nuclear Energy ,Subcritical Transmuting Accelerated Regenerative Technology ,Partner At Union Square Ventures ,United Nations ,Tiny Supercomputer Investment Co ,Research Facility ,Argonne National Laboratory ,Polytechnic Institute Of Lausanne ,Scientific Research ,Paul Scherrer Institute ,Subcritical Transmuting Accelerated Regenerative ,Managing Partner ,Union Square ,Steel Atlas ,Square Ventures ,House Of Ventures ,Presight Capital ,Verve Ventures ,Tiny Supercomputer Investment ,More Technical Roles ,New Research ,International Collaborations With Leaders ,Polytechnic Institute ,First Approach ,Lower Cost Engineering ,